David McIntosh: PPTA Calls for Action on the Global Shortage of Plasma-Derived Medicines
David McIntosh, Founder and Chair at United Plasma Action, shared Plasma Protein Therapeutics Association’s post on LinkedIn:
“Huge thanks and congratulations are due to the PPTA team, the authors and editors for this milestone post, especially to Doctor Hartmann.
In a World where millions die each year because of chronic global shortages of Plasma-Derived Medicines – and where many authorities appear not yet to have woken up to this shameful fact – it is very encouraging to see the premier industry representative organisation speaking up in this way.
Given that 90% of the current global supply of pharmaceutical grade plasma comes to us thanks to the commercial Plasma Industry, their representative is certainly well placed to speak up.
All we need now is for the WHO, the EU and Governments round the World to actually stop, look and listen up – pay due attention to the evidence – and ACT accordingly.
Millions of lives depend upon their doing so…”
Plasma Protein Therapeutics Association (PPTA) shared a post on LinkedIn:
“A secure supply of source plasma is fundamental to ensuring patients have access to plasma-derived medicines.
The Annals of Blood special series on Source Plasma examines the many factors that shape this critical supply. From collection and donor safety to regulation, manufacturing, pathogen safety, and access, expert papers detail the complex global plasma web.
Julia Fabens, Michelle Fransen, James Knowles, Evelina Kozubovska, Joshua Penrod, Crystal Phillips, Dr. Toby Simon, and Halide Tuna, contributed their expertise to this important, ongoing conversation.
Read the series to explore the challenges and opportunities shaping the future of source plasma.”
Other posts featuring David McIntosh on Hemostasis Today.
-
Oct 30, 2026, 03:59Emil List Larsen: Identifying SERPINC1 Variants and Limitations of Routine Antithrombin Testing
-
Oct 30, 2026, 02:43D Chandra: Reduce the Apixaban Dose for a Patient with VTE and a Creatinine Clearance of 25?
-
Oct 30, 2026, 02:38Spencer Dorn: Why AI Decision Support Must Integrate Local Clinical Context
-
Oct 30, 2026, 02:33Jens Eschen: Randomized Controlled Trial on Acute Aortic Dissection Anticoagulation Strategies
-
Oct 30, 2026, 02:23Mavis Agnes Kisakye: Landmark Study Paves the Way for Standardized Bleeding Disorder Guidelines in Uganda
-
Oct 30, 2026, 02:16Zelalem G. Moges: Recognizing Leech Infestation in Rural Patients with Unexplained Vaginal Bleeding
-
Oct 29, 2026, 23:09Brad Flora: Reaching 15 Gallons of Lifetime Blood Donations
-
Oct 29, 2026, 23:07David McIntosh: Why We Need Thousands of Blood Donations Every Day
-
Oct 29, 2026, 23:07Tamer El-Sayed: Could Anaemia Be an Overlooked Factor in Patients with Intermittent Claudication?